Post-COVID-19 era sero-surveillance of anti-measles IgM and IgG antibodies among asymptomatic Tanzanian children aged 3 to 15 years Journal.

IF 3.1 4区 医学 Q3 IMMUNOLOGY
Victoria Shayo, Lilian Nkinda, Salim S Masoud, Ester Mwendapole, Joan Thomas, Juma Kisuse, George Bwire, Upendo Kibwana, Mtebe Majigo, Joseph G Kimaro, Sayoki Mfinanga, Mbazi Senkoro, Eligius Lyamuya, Mecky I Matee
{"title":"Post-COVID-19 era sero-surveillance of anti-measles IgM and IgG antibodies among asymptomatic Tanzanian children aged 3 to 15 years Journal.","authors":"Victoria Shayo, Lilian Nkinda, Salim S Masoud, Ester Mwendapole, Joan Thomas, Juma Kisuse, George Bwire, Upendo Kibwana, Mtebe Majigo, Joseph G Kimaro, Sayoki Mfinanga, Mbazi Senkoro, Eligius Lyamuya, Mecky I Matee","doi":"10.1007/s12026-025-09645-2","DOIUrl":null,"url":null,"abstract":"<p><p>In July 2022, during the COVID-19 era, Tanzania reported over 1500 laboratory-confirmed measles cases and more than 30 deaths, with about 80% of the children not vaccinated. The response was an intensive vaccination campaign that targeted under-fives across the country. This was a cross-sectional measles-serosurveillance study conducted in 2024, after the COVID-19 era, in Dar es Salaam. The study involved children aged 3 to 15 years who were attending Temeke Regional Referral Hospital (TRRH) in Dar es Salaam, Tanzania, during the study period. Children were screened for anti-measles IgM and IgG antibodies using the NovaLisa Measles ELISA kit (NovaTec Immunodiagnostica GmbH® kit) and were categorized into four groups: (i) immune to measles (presence of anti-measles virus IgG and absence of anti-measles virus IgM), (ii) having reactivated measles (presence of both anti-measles virus IgG and anti-measles virus IgM), (iii) recently contracted measles (absence of anti-measles virus IgG and presence of IgM), and (iv) vulnerable (absence of both anti-measles virus IgG and anti-measles virus IgM). Of the 155 collected blood samples, 32 (20.64%) were positive for IgM, 35 (22.58%) cases were IgG-positive, and 74 (47.74%) had both IgM and IgG anti-measles antibodies. Based on these results, 35 (22.58%) children were determined to be immune, 74 (47.74%) were adjudged to have reactivated measles, 32 (20.64%) had recently contracted measles, and 14 (9.03%) were susceptible to measles infection. We found no significant association between gender, parents' education or income, frequency of facility visits, parents' knowledge of measles, and the presence of measles symptoms with IgM and IgG antibodies. The only significant association was age and IgM, being highest (22.58%) in children aged 3-5 years (P = 0.014), indicating risk of contracting measles in early childhood. This study provides an update regarding the current immunity status of children against measles infection in the post-COVID-19 era. Our study clearly indicates a need to improve measles immunization activities and strategies. The Government of Tanzania, through the Ministry of Health, should work together with international agencies such as the World Health Organization (WHO) and United Nations International Children's Emergency Fund (UNICEF) and other stakeholders to ramp up efforts to meet the target of 95% vaccination coverage.</p>","PeriodicalId":13389,"journal":{"name":"Immunologic Research","volume":"73 1","pages":"87"},"PeriodicalIF":3.1000,"publicationDate":"2025-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunologic Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s12026-025-09645-2","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

In July 2022, during the COVID-19 era, Tanzania reported over 1500 laboratory-confirmed measles cases and more than 30 deaths, with about 80% of the children not vaccinated. The response was an intensive vaccination campaign that targeted under-fives across the country. This was a cross-sectional measles-serosurveillance study conducted in 2024, after the COVID-19 era, in Dar es Salaam. The study involved children aged 3 to 15 years who were attending Temeke Regional Referral Hospital (TRRH) in Dar es Salaam, Tanzania, during the study period. Children were screened for anti-measles IgM and IgG antibodies using the NovaLisa Measles ELISA kit (NovaTec Immunodiagnostica GmbH® kit) and were categorized into four groups: (i) immune to measles (presence of anti-measles virus IgG and absence of anti-measles virus IgM), (ii) having reactivated measles (presence of both anti-measles virus IgG and anti-measles virus IgM), (iii) recently contracted measles (absence of anti-measles virus IgG and presence of IgM), and (iv) vulnerable (absence of both anti-measles virus IgG and anti-measles virus IgM). Of the 155 collected blood samples, 32 (20.64%) were positive for IgM, 35 (22.58%) cases were IgG-positive, and 74 (47.74%) had both IgM and IgG anti-measles antibodies. Based on these results, 35 (22.58%) children were determined to be immune, 74 (47.74%) were adjudged to have reactivated measles, 32 (20.64%) had recently contracted measles, and 14 (9.03%) were susceptible to measles infection. We found no significant association between gender, parents' education or income, frequency of facility visits, parents' knowledge of measles, and the presence of measles symptoms with IgM and IgG antibodies. The only significant association was age and IgM, being highest (22.58%) in children aged 3-5 years (P = 0.014), indicating risk of contracting measles in early childhood. This study provides an update regarding the current immunity status of children against measles infection in the post-COVID-19 era. Our study clearly indicates a need to improve measles immunization activities and strategies. The Government of Tanzania, through the Ministry of Health, should work together with international agencies such as the World Health Organization (WHO) and United Nations International Children's Emergency Fund (UNICEF) and other stakeholders to ramp up efforts to meet the target of 95% vaccination coverage.

新冠肺炎疫情后坦桑尼亚3 ~ 15岁无症状儿童抗麻疹IgM和IgG抗体的血清监测
2022年7月,在COVID-19时期,坦桑尼亚报告了1500多例实验室确诊的麻疹病例和30多人死亡,其中约80%的儿童没有接种疫苗。应对措施是针对全国五岁以下儿童开展密集的疫苗接种运动。这是2019冠状病毒病时代结束后,于2024年在达累斯萨拉姆进行的一项横断面麻疹血清监测研究。该研究涉及在研究期间在坦桑尼亚达累斯萨拉姆的Temeke地区转诊医院(TRRH)就诊的3至15岁儿童。使用NovaLisa麻疹ELISA试剂盒(NovaTec Immunodiagnostica GmbH®kit)筛选儿童抗麻疹IgM和IgG抗体,并将其分为四组:(一)对麻疹免疫(有抗麻疹病毒IgG,但没有抗麻疹病毒IgM),(二)麻疹复燃(有抗麻疹病毒IgG和抗麻疹病毒IgM),(三)最近感染麻疹(没有抗麻疹病毒IgG,但有IgM),以及(四)易感(既没有抗麻疹病毒IgG,也没有抗麻疹病毒IgM)。155份血样中,IgM阳性32例(20.64%),IgG阳性35例(22.58%),IgM和IgG双抗74例(47.74%)。结果确定免疫儿童35例(22.58%),麻疹复活儿童74例(47.74%),近期麻疹病例32例(20.64%),麻疹易感儿童14例(9.03%)。我们发现性别、父母的受教育程度或收入、去医院的频率、父母对麻疹的了解以及是否有IgM和IgG抗体的麻疹症状之间没有显著的关联。只有年龄和IgM有显著相关性,3-5岁儿童的IgM最高(22.58%)(P = 0.014),表明儿童早期有感染麻疹的风险。本研究提供了后covid -19时代儿童麻疹感染免疫现状的最新信息。我们的研究清楚地表明需要改进麻疹免疫活动和策略。坦桑尼亚政府应通过卫生部与世界卫生组织(世卫组织)和联合国国际儿童紧急基金会(儿基会)等国际机构以及其他利益攸关方合作,加紧努力,实现95%疫苗接种覆盖率的目标。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Immunologic Research
Immunologic Research 医学-免疫学
CiteScore
6.90
自引率
0.00%
发文量
83
审稿时长
6-12 weeks
期刊介绍: IMMUNOLOGIC RESEARCH represents a unique medium for the presentation, interpretation, and clarification of complex scientific data. Information is presented in the form of interpretive synthesis reviews, original research articles, symposia, editorials, and theoretical essays. The scope of coverage extends to cellular immunology, immunogenetics, molecular and structural immunology, immunoregulation and autoimmunity, immunopathology, tumor immunology, host defense and microbial immunity, including viral immunology, immunohematology, mucosal immunity, complement, transplantation immunology, clinical immunology, neuroimmunology, immunoendocrinology, immunotoxicology, translational immunology, and history of immunology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信